Add movement disorders patients to the long list of people whose health could suffer under the Trump administration’s proposal to loosen Medicare protections on six classes of medications for high-risk diseases. In current practice, Medicare prescription drug plans must cover all (or “substantially all”) drugs in six classes. These include drugs for life-threatening conditions such […]
An upcoming meeting will give people with movement disorders a chance to tell Food and Drug Administration regulators their story – the story of their physical symptoms as well as their emotional ones.
Last month, the federal government proposed changes to Medicare’s billing rules. The net effect: Doctors will spend less time with their patients. As a physician myself, I know that’s not necessarily a good thing.
This month, patients with Huntington’s disease are asking for what worked for patients with ALS and other debilitating diseases–parity to accessing Medicare benefits. The request is a focal point for May’s Huntington’s Disease Awareness Month.
More than 3.4 million people in the United States live with epilepsy, a neurological disorder that can cause seizures and violent muscle spasms. This February 12, International Epilepsy Day, patients come together to share their experiences – including the struggle to access necessary medication.
Most all of us know someone living in a long-term care facility – a friend, a former neighbor, a family member. But not all may be aware of a recent debate about the use of a certain type of medication – antipsychotic medication – for seniors living in these facilities.